{
  "company": {
    "name": "Somagenetix",
    "website": "https://somagenetix.com/",
    "record": "https://startuphistory.org/c/somagenetix.com"
  },
  "status": null,
  "history_since": "2024-11-03T07:43:38.000Z",
  "baseline": {
    "snapshot_id": "295ff6ac32bd253fd084ee979cd43f9c8a0d7132c7bc2896623192c1d6a26c9d",
    "observed_at": "2024-11-03T07:43:38.000Z",
    "headline": null,
    "description": "Discover Somagenetix, a biotech leader developing innovative gene therapies to cure inherited genetic disorders at their DNA core. Explore our cutting-edge PhagoCure® platform and life-changing treatm",
    "evidence": "https://web.archive.org/web/20241103074338/https://www.somagenetix.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T20:56:57.141Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-01-13T10:27:43.000Z",
      "variants": [
        {
          "headline": "Somagenetix | Ex-vivo Gene Therapy for CGD & Phagocyte Disorders",
          "subhead": "Ex-vivo gene therapy for phagocyte disorders. Somagenetix develops lentiviral HSC programs, starting with CGD—advancing safe, durable, one-time treatments.",
          "observed_at": "2026-01-13T10:27:43.000Z",
          "evidence": "https://web.archive.org/web/20260113102743/https://www.somagenetix.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Somagenetix | Ex-vivo Gene Therapy for CGD & Phagocyte Disorders",
      "subhead": "Ex-vivo gene therapy for phagocyte disorders. Somagenetix develops lentiviral HSC programs, starting with CGD—advancing safe, durable, one-time treatments.",
      "from": "2026-01-13T10:27:43.000Z",
      "to": "2026-01-13T10:27:43.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20260113102743/https://www.somagenetix.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2026-01-13T10:27:43.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T20:56:57.141Z",
      "variants": [
        {
          "headline": "CURING GENETIC DISORDERS",
          "subhead": "Ex-vivo gene therapy for phagocyte disorders. Somagenetix develops lentiviral HSC programs, starting with CGD—advancing safe, durable, one-time treatments.",
          "observed_at": "2026-11-06T20:56:57.141Z",
          "evidence": "https://www.somagenetix.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "CURING GENETIC DISORDERS",
      "subhead": "Ex-vivo gene therapy for phagocyte disorders. Somagenetix develops lentiviral HSC programs, starting with CGD—advancing safe, durable, one-time treatments.",
      "from": "2026-11-06T20:56:57.141Z",
      "to": "2026-11-06T20:56:57.141Z",
      "captures": 1,
      "evidence": "https://www.somagenetix.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-06T20:56:57.141Z"
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Orchard Therapeutics",
      "record": "https://startuphistory.org/c/orchard-tx.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "direct",
      "why": "Both develop ex vivo autologous HSC gene therapies for rare inherited disorders."
    },
    {
      "name": "Rocket Pharmaceuticals",
      "record": "https://startuphistory.org/c/rocketpharma.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both develop lentiviral and other gene therapies targeting rare inherited diseases."
    },
    {
      "name": "Garuda Therapeutics",
      "record": "https://startuphistory.org/c/garudatx.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both focus on hematopoietic stem cell–based therapies for rare blood and immune disorders."
    },
    {
      "name": "Cellogen Therapeutics",
      "record": "https://startuphistory.org/c/cellogentherapeutics.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both work on gene therapy approaches for blood-related disorders using engineered cells."
    },
    {
      "name": "Genespire",
      "record": "https://startuphistory.org/c/genespire.com",
      "basis": "ai_judged",
      "category": null,
      "overlap": "partial",
      "why": "Both develop lentiviral-based gene therapies for rare genetic diseases, though via different delivery routes."
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Somagenetix” company record, https://startuphistory.org/c/somagenetix.com"
}